Early employee and founding member of the San Francisco office. Built enterprise-level partnerships with Top 25 biopharma and select biotechs focused on oncology evidence generation in Flatiron's core markets (USA, UK, Germany, and Japan). Managed a team of 8 and grew revenue on the West Coast from <$1M to over $100M per year. Held a leading role in all commercialization and GTM motions for the Flatiron RWE portfolio and owned joint sales management activities with corporate partners including Datavant, Komodo Health, and Foundation Medicine. Frequently owned commercial inputs into Flatiron's long term growth strategy and partnering activities.

Mentor in the FirstRound Fast Track Program in which I supported emerging business development leaders in the health tech space.

Consultant and thought partner to leading biopharma companies on a range of business issues across therapy areas and geographies. Primarily served as a global project manager responsible for overall project execution. Particular focus on global pricing and market access strategy in oncology.

Molecular biology lab role focused on transgenic biology and technology development. Developed novel methods for using next generation sequencing to increase lab output.